Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 229

1.

T300A variant of AT16L1 gene in a cohort of Algerian Crohn disease patients.

Aida I, Meddour Y, Kadiri H, Smara M, Bousseloub A, Kecili L, Gamar L, Belhocine K, Boussafsaf MA, Debzi N, Aouichat-Bouguerra S, Chaib S.

Curr Res Transl Med. 2018 Mar;66(1):9-14. doi: 10.1016/j.retram.2018.01.002. Epub 2018 Mar 5.

PMID:
29519712
2.

Autoantibodies and Gastrointestinal Symptoms in Colombian Children with Juvenile Idiopathic Arthritis.

Gonzalez T, Malagon C, Guarnizo P, Mosquera AC, Chila-Moreno L, Romero-Sanchez C.

Curr Rheumatol Rev. 2018;14(2):163-171. doi: 10.2174/1573397114666180108110429.

PMID:
29308742
3.

The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient.

Smids C, Horjus Talabur Horje CS, Groenen MJM, van Koolwijk EHM, Wahab PJ, van Lochem EG.

Scand J Gastroenterol. 2017 Oct;52(10):1104-1112. doi: 10.1080/00365521.2017.1344875. Epub 2017 Jun 29.

PMID:
28661185
4.

Serologic testing of a panel of five antibodies in inflammatory bowel diseases: Diagnostic value and correlation with disease phenotype.

Wang ZZ, Shi K, Peng J.

Biomed Rep. 2017 Apr;6(4):401-410. doi: 10.3892/br.2017.860. Epub 2017 Feb 17.

5.

Serologic antibodies in relation to outcome in postoperative Crohn's disease.

Hamilton AL, Kamm MA, De Cruz P, Wright EK, Selvaraj F, Princen F, Gorelik A, Liew D, Lawrance IC, Andrews JM, Bampton PA, Sparrow MP, Florin TH, Gibson PR, Debinski H, Gearry RB, Macrae FA, Leong RW, Kronborg I, Radford-Smith G, Selby W, Bell SJ, Brown SJ, Connell WR.

J Gastroenterol Hepatol. 2017 Jun;32(6):1195-1203. doi: 10.1111/jgh.13677.

PMID:
27976801
6.

Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.

Zhang S, Luo J, Li J, Wu Z, Hu C, Li P, Deng C, Zhang F, Qian J, Li Y.

Clin Chem Lab Med. 2017 May 1;55(6):865-875. doi: 10.1515/cclm-2016-0658.

PMID:
27831916
7.

Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohn's Disease.

Degenhardt F, Dirmeier A, Lopez R, Lang S, Kunst C, Roggenbuck D, Reinhold D, Szymczak S, Rogler G, Klebl F, Franke A, Rieder F.

Inflamm Bowel Dis. 2016 Nov;22(11):2648-2657.

8.

Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.

Hoarau G, Mukherjee PK, Gower-Rousseau C, Hager C, Chandra J, Retuerto MA, Neut C, Vermeire S, Clemente J, Colombel JF, Fujioka H, Poulain D, Sendid B, Ghannoum MA.

MBio. 2016 Sep 20;7(5). pii: e01250-16. doi: 10.1128/mBio.01250-16.

9.

The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial disease.

Cianci R, Lolli S, Pagliari D, Gambassi G, Frosali S, Marmo R, Melioli G, Orlando A, Newton EE, Serone E, Landolfi R, Pandolfi F, Frezza D.

Eur Rev Med Pharmacol Sci. 2016 Sep;20(17):3618-27.

10.

pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.

Birimberg-Schwartz L, Wilson DC, Kolho KL, Karolewska-Bochenek K, Afzal NA, Spray C, Romano C, Lionetti P, Hauer AC, Martinez-Vinson C, Veres G, Escher JC, Turner D; paediatric IBD Porto group of ESPGHAN.

Inflamm Bowel Dis. 2016 Aug;22(8):1908-14. doi: 10.1097/MIB.0000000000000784.

PMID:
27135480
11.

Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis.

Choung RS, Princen F, Stockfisch TP, Torres J, Maue AC, Porter CK, Leon F, De Vroey B, Singh S, Riddle MS, Murray JA, Colombel JF; PREDICTS Study Team.

Aliment Pharmacol Ther. 2016 Jun;43(12):1300-10. doi: 10.1111/apt.13641. Epub 2016 Apr 27.

12.

Assessment of Fecal ASCA Measurement as a Biomarker of Crohn Disease in Pediatric Patients.

Tang V, Valim C, Moman R, Richman A, Zhou J, Ramgopal V, Albert R, Boone JH, Rufo PA.

J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):248-253. doi: 10.1097/MPG.0000000000001244.

PMID:
27111346
13.

Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.

Amcoff K, Joossens M, Pierik MJ, Jonkers D, Bohr J, Joossens S, Romberg-Camps M, Nyhlin N, Wickbom A, Rutgeerts PJ, Tysk C, Bodin L, Colombel JF, Vermeire S, Halfvarson J.

J Crohns Colitis. 2016 Jun;10(6):695-702. doi: 10.1093/ecco-jcc/jjw021. Epub 2016 Jan 27.

PMID:
26818662
14.

A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables.

Siegel CA, Horton H, Siegel LS, Thompson KD, Mackenzie T, Stewart SK, Rice PW, Stempak JM, Dezfoli S, Haritunians T, Levy A, Baek M, Milgrom R, Dulai PS, Targan SR, Silverberg MS, Dubinsky MC, McGovern DP.

Aliment Pharmacol Ther. 2016 Jan;43(2):262-71. doi: 10.1111/apt.13460. Epub 2015 Nov 15.

15.

Gastrointestinal comorbidities in patients with psoriasis in the Czech Republic: The results of 189 patients with psoriasis and 378 controls.

Juzlova K, Votrubova J, Dzambova M, Gopfertova D, Hercogova J, Smerhovsky Z.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Mar;160(1):100-5. doi: 10.5507/bp.2015.048. Epub 2015 Oct 21.

16.

Diagnostic Potential of Zymogen Granule Glycoprotein 2 Antibodies as Serologic Biomarkers in Chinese Patients With Crohn Disease.

Zhang S, Wu Z, Luo J, Ding X, Hu C, Li P, Deng C, Zhang F, Qian J, Li Y.

Medicine (Baltimore). 2015 Oct;94(42):e1654. doi: 10.1097/MD.0000000000001654.

17.

Diagnostic and clinical significance of Crohn's disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodies.

Pavlidis P, Komorowski L, Teegen B, Liaskos C, Koutsoumpas AL, Smyk DS, Perricone C, Mytilinaiou MG, Stocker W, Forbes A, Bogdanos DP.

Clin Chem Lab Med. 2016 Feb;54(2):249-56. doi: 10.1515/cclm-2015-0376.

PMID:
26351932
18.

Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn's Disease.

Michaels MA, Jendrek ST, Korf T, Nitzsche T, Teegen B, Komorowski L, Derer S, Schr√∂der T, Baer F, Lehnert H, B√ľning J, Fellerman K, Sina C.

Inflamm Bowel Dis. 2015 Dec;21(12):2864-72. doi: 10.1097/MIB.0000000000000564.

PMID:
26273818
19.

Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.

Goren I, Yahav L, Tulchinsky H, Dotan I.

Inflamm Bowel Dis. 2015 Oct;21(10):2289-95. doi: 10.1097/MIB.0000000000000487.

PMID:
26197448
20.

Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn's Disease.

Lakatos PL, Sipeki N, Kovacs G, Palyu E, Norman GL, Shums Z, Golovics PA, Lovasz BD, Antal-Szalmas P, Papp M.

J Crohns Colitis. 2015 Oct;9(10):891-8. doi: 10.1093/ecco-jcc/jjv127. Epub 2015 Jul 18.

PMID:
26188353

Supplemental Content

Loading ...
Support Center